Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?

Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?

Objectives: We critically evaluated the quality of evidence and quality of harm reporting in clinical trials that evaluated the effectiveness of hydroxychloroquine (HCQ) or chloroquine (CQ) for the treatment of coronavirus disease 2019 (COVID-19). Study design and setting: Scientific databases were...

Full description

Bibliographic Details
Main Authors: Faizan Mazhar, Muhammad Abdul Hadi, Chia Siang Kow, Albaraa Mohammed N. Marran, Hamid A. Merchant, Syed Shahzad Hasan
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:International Journal of Infectious Diseases
Subjects:
Coronavirus 2019
Harm reporting
Adverse events
Hydroxychloroquine
Chloroquine
Online Access:http://www.sciencedirect.com/science/article/pii/S120197122032186X

Internet

http://www.sciencedirect.com/science/article/pii/S120197122032186X

Similar Items